Tag Archive for: Collaborative Drug Discovery

servier insilico
R&D collaborations

Servier and Insilico sign an $888 million AI oncology discovery deal

On January 4, the French pharma group Servier and the AI drug discovery Insilico Medicine announced a collaboration worth up to $888 million. Insilico will receive up to $32 million from Servier for a multi-year research and development collaboration to discover and develop oncology therapies using Insilico’s artificial intelligence (AI)-driven drug discovery platform and Servier’s cancer development expertise.

Read more
Visualising structures of monomers from macromolecules registered in CDD Vault Collaborate Drug Discovery Inc.
Data Management

Enhancing macromolecule drug discovery with CDD

The landscape of macromolecule drug discovery is evolving rapidly, with oligonucleotides and peptides leading the way in innovative therapeutic applications. CDD Vault, a leading scientific data management system, significantly improves the way researchers manage macromolecule data by introducing a dedicated Macromolecule mode that seamlessly integrates with modern workflows.

Read more